Clinical Trial Update: Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pre-operative or peri-operative doxorubicin regimen in patients with locally advanced, resectable gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Gastric Cancer, Locally Advanced Malignant Neoplasm | Phase 2 | Status: COMPLETED